Mroczkowski Paweł, Hać Stanisław, Mik Michał, Berut Maciej, Dziki Łukasz, Kube Rainer, Sledziński Zbigniew, Lippert Hans, Dziki Adam
Department of General, Visceral and Vascular Surgery, Otto von Guericke University of Magdeburg, Germany.
Pol Przegl Chir. 2011 Mar;83(3):144-9. doi: 10.2478/v10035-011-0022-8.
When compared with other EU countries, Poland is in the last place in terms of efficacy of rectal cancer treatment. In order to remedy this situation, in 2008 Polish centres were given the opportunity to participate in an international programme for evaluating the treatment efficacy.The aim of the study was to present the results obtained during the first two years of research.
The study protocol covered 71 questions concerning demographic data, diagnostics, risk factors, peri- and post-operative complications, histopathology, and treatment plan at discharge. The patient and unit data were kept confidential.
From 1 January 2008 to 30 December 2009, there were 709 patients recorded, of which 55.9% were males. At least one risk factor was found in approx. 3/4 of patients, while approx. 1/3 of patients were classified to group 3 and 4 according to ASA. The mean distance of the tumour from the anal margin was 8.5 cm; approx. 70% of patients were in the clinical stages cT3 and cT4; metastases were observed in 18.8%. Transrectal endoscopic ultrasonography (TREUS) was performed in 23.7% of patients, magnetic resonance imaging (MRI) in 2.5% and computed tomography (CT) scan - in 48.1%. In close to half of the patients, anterior or low anterior resection of the rectum was performed, and abdominoperineal resection in 1/4 of the patients. Anastomotic leakage was seen in 3.8% of patients, while 1.8% died during hospitalisation.
It should be strived after that all the centres undertaking the treatment of rectal cancer should participate in the quality assurance programme. This should enable the achievement of good therapeutic results in patients with rectal cancer treated in Polish centres.
与其他欧盟国家相比，波兰在直肠癌治疗效果方面处于末位。为改善这种情况，2008年波兰各中心获得了参与一项评估治疗效果的国际项目的机会。本研究的目的是呈现前两年研究期间所取得的结果。
研究方案涵盖了71个问题，涉及人口统计学数据、诊断、危险因素、围手术期和术后并发症、组织病理学以及出院时的治疗方案。患者和单位数据均予以保密。
2008年1月1日至2009年12月31日，共记录了709例患者，其中55.9%为男性。约3/4的患者至少存在一种危险因素，而约1/3的患者根据美国麻醉医师协会（ASA）分类属于3级和4级。肿瘤距肛缘的平均距离为8.5厘米；约70%的患者处于临床cT3和cT4期；观察到转移的患者占18.8%。23.7%的患者接受了经直肠内镜超声检查（TREUS），2.5%的患者接受了磁共振成像（MRI）检查，48.1%的患者接受了计算机断层扫描（CT）检查。近一半的患者接受了直肠前切除术或低位前切除术，1/4的患者接受了腹会阴联合切除术。3.8%的患者出现吻合口漏，1.8%的患者在住院期间死亡。
应努力使所有开展直肠癌治疗的中心参与质量保证项目。这应能使波兰各中心治疗的直肠癌患者取得良好的治疗效果。
